OpenAI Acquires Orchestra Bio to Link Research AI with Drug Development
ryanmerket · reddit · 2026-10-21
OpenAI has acquired Orchestra Bio, aiming to connect its research AI with drug-development operations and accelerate AI-driven biotech workflows. Financial terms were not disclosed. The deal marks another step in OpenAI's push into life sciences and AI for Science.
Related event: OpenAI Acquires Orchestra Bio to Bring AI Agents into Drug Development(13 posts)→
More from Venture
- Anthropic's draft IPO filing: $16.3B H1 revenue, $80B net loss, $750B compute plans — kimmonismus · 2026-10-21
- Metaphor claims cloud coding agent beats Claude Code with 25% fewer tokens — Scobleizer · 2026-10-21
- Meta's AI companion Muse hits 10M US downloads in 40 days, joining Threads in rare club — kimmonismus · 2026-10-21
- HSBC says CoreWeave shares to drop 30%+ as ROIC of 8.9% lags borrowing costs — GaryMarcus · 2026-10-21
- Anthropic reportedly told investors its revenue growth is slowing sharply — SumitGup · 2026-10-21
- Polymarket CEO caught expensing private jets; Exa cofounders fly premium economy only — TheIshanGoswami · 2026-10-21